Tremendous progress has been made in understanding the role of T cell immunity in acute
and convalescent COVID-19 infection. Here, we shed light on the “known unknowns” of …

… of diverse immune cells with evolving states in COVID-19, here we used multimodal single-…
COVID-19 patients. In addition to providing a time-resolved single-cell atlas of COVID-19 for …

… the use of COVID-19 “immunity passports” or “immunity certificates” or “immunity licenses” ie
… with those who have certificates of immunity to COVID 19 rather than seeking for infection. …

… novel coronavirus severe acute respiratory syndrome coronavirus 2 causing the Coronavirus
disease (COVID-19) … management strategies for deadly infectious diseases like COVID-19. …

… immunity. This happens through the regulation of immunological markers and their cells.
Therefore, the COVID-19 … problems imposed by the COVID-19 pandemic compromise the …

… clinical trials of COVID-19 vaccine candidates. Although COVID-19 vaccine development
is … to have an impact on the first wave of the ongoing COVID-19 pandemic. Nevertheless, …

… in recovered COVID-19 patients. … COVID-19 patients with different degrees of clinical
symptoms will provide important insights into understanding the protective immunity for COVID-19, …

… We use our core shielding model as the basis for application to COVID-19, as it represents
the … model of shield immunity to the epidemiological dynamics of the COVID-19 pandemic. For …

… calculate the minimum (‘critical’) level of population immunity, P crit , acquired via vaccination
or naturally-induced (ie after recovery from COVID-19), to halt the spread of infection in that …

… Current COVID-19 therapy involves only treatment of … exposure and enhancing individual
immunity. Studies have shown that … also to enhance psychoneuro immunity against COVID-19. …